Revenue: As of FY2025 Q1, the actual value is USD 8.015 M.EPS: As of FY2025 Q1, the actual value is USD 0.01.EBIT: As of FY2025 Q1, the actual value is USD 684.42 K.<h3>Segment Revenue</h3><ul><li>Revenues from Underwriting Modeling (ICE): $2,351,984 for the three months ended March 31, 2025, compared to $1,784,635 for the same period in 2024, representing a 31.8% increase.</li><li>Revenues from Fees: $5,663,000 for the three months ended March 31, 2025, compared to $3,340,296 for the same period in 2024, representing a 69.5% increase.</li></ul><h3>Operational Metrics</h3><ul><li>Net Income: $498,592 for the three months ended March 31, 2025, compared to $100,536 for the same period in 2024.</li><li>Gross Profit: $5,355,399 for the three months ended March 31, 2025, compared to $4,135,020 for the same period in 2024.</li><li>Operating Expenses: $4,874,741 for the three months ended March 31, 2025, compared to $3,802,598 for the same period in 2024.</li><li>Operating Margin: 8.6% for the three months ended March 31, 2025, compared to 3.8% for the same period in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Operating Cash Flow: $527,353 for the three months ended March 31, 2025, compared to -$680,212 for the same period in 2024.</li><li>Free Cash Flow: Not explicitly stated, but net cash used in investing activities was -$703,475 for the three months ended March 31, 2025.</li></ul><h3>Unique Metrics</h3><ul><li>Adjusted EBITDA: $1,228,211 for the three months ended March 31, 2025, compared to $467,209 for the same period in 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: Health In Tech, Inc. plans to continue investing in technology and innovation to drive advancements in automation and enhance operational efficiency. The company aims to expand its network of brokers, TPAs, and other third-party agents to grow its business.</li><li>Non-Core Business: The company is exploring collaborations with insurance carriers to offer new products and plans, which is essential for expanding its portfolio of products and services.</li></ul>

Health In Tech | 10-Q: FY2025 Q1 Revenue: USD 8.015 M